ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief

February 7, 2014

Peter Shields Named Deputy Director At Ohio State

September 16, 2011

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

NIH To Replace RAC With New Committee

July 19, 1996

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

Epstein Back With New Attack On “Establishment” In Congressional Record

November 6, 1987